C4 Therapeutics (CCCC) Revenue (QoQ) (2019 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | C4 Therapeutics | 561.03 Mn | 325.36 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -44.15% |
| Dec 31, 2025 | -1.91% |
| Sep 30, 2025 | 73.76% |
| Jun 30, 2025 | -10.71% |
| Mar 31, 2025 | 39.81% |
| Dec 31, 2024 | -66.30% |
| Sep 30, 2024 | 27.95% |
| Jun 30, 2024 | 295.06% |
| Mar 31, 2024 | -6.81% |
| Dec 31, 2023 | -70.55% |
| Sep 30, 2023 | 315.62% |
| Jun 30, 2023 | -29.13% |
| Mar 31, 2023 | 31.71% |
| Dec 31, 2022 | -57.74% |
| Sep 30, 2022 | -51.18% |
| Jun 30, 2022 | 80.74% |
| Mar 31, 2022 | -61.88% |
| Dec 31, 2021 | 136.21% |
| Sep 30, 2021 | -13.10% |
| Jun 30, 2021 | 31.71% |
| Mar 31, 2021 | -10.12% |
| Dec 31, 2020 | -2.19% |
| Sep 30, 2020 | -12.65% |
| Jun 30, 2020 | 41.87% |
| Mar 31, 2020 | -16.97% |
| Dec 31, 2019 | 53.04% |